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Previously w¢ have shown that the COOH.terminal fr gment (A4CT) of flu= Ahhcimcr amyloid protein precursor (APP), which at theN H_.-tcrminus 
¢arricl the ~quencc of the amyloid .8A4 protein, forms highly inrmluble aggre~tes [EMBO .I. (1988) 7. 949-957]. Here ~ report thai aggregation 
is prevented if A4CT is ¢xpreucd invitro with tt signal ~=quenee at the NH:.terminus (SPA4CT) under conditions which allow membrane immrtion. 
Aglirellates from gPA4CT are obtained alter removal of membranes h)' chlorofon~methunol extraction or heating. 
A4CT; In vitro translation; AIIllrqlation; Alxheimer's disca~ 
l, INTRODUCTION 
The histopathological features of Alzheimer's disease 
(AD)  and the mechanisms underlying amyloid deposi- 
t ion in AD have been intensively investigated [2-7]. The 
isolation and sequence analysis of#A4 [3-6] from intra- 
~llular and extracellalar amyloid in AD and Dawn's 
syndrome brains has led to the isolation and character- 
ization of the family of amyloid protein precursors 
(APP's) as glycosylated, tyrosine-sulfated transmem. 
brane proteins [8-12], The ~A4 protein is encoded 
within the transmembrane and extracellular domains of 
the APP's [8]. 
The normal route of APP processing involves cleav- 
age of APP within the,aA4 sequence [12-14]. This sug- 
gests that the NHa-terminus of'the amyloid/~A4 protein 
is not produced by the normal cleavage which leads to 
shedding of the extraceliular part of cell-surface trans- 
membrane APP's. 
The exact amyloidogeni¢ mechanism by which pA4 
is cleaved from APP and deposited in AD remains un- 
known, although our earlier [1] and re ins  studies [15] 
suggest that th¢ initial step of the abnormal processing 
of full-length APP in Alzheimer's disease may occur at 
the NH,.terminus of the 3A4 sequence and generate a 
COOH-terminal fragment of 100 residues (A4CT), 
which includes the amyloid pA4 sequence, and the 
transmembrane and cytoplasmic domains of all known 
transmembrane APP forms. 
To stud~/the amyloidogenic properties of this hypo- 
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thetical intermediate in the process of amyloid forma- 
tion, we expressed these COOH.terminal 100 residues 
with (SPA4CT) and without (A4CT) the APP signal 
sequence, 
Here we =how that expression of this APP fragment 
in the rabbit reticulocyte ly~ate (RRL) resulted in an 
aggregating protein, Membrane insertion of A4C'T ob- 
tained by expression of" gPA4CT in the presence of  dog 
pancreas membranes prevents aggregation. Post-trans- 
lational removal of the membranes led to aggregation, 
2. EXPERIMENTAL 
2,1, Clonhtg pmcedurr~" 
Preparation f plaimid DNA, restriction e zyme digestion, al~ros¢ 
8el ¢lectrophor~is of DNA, DNA libation and bacterial transform;t. 
tion were carried out as deicri~d by Maniatis et al, [16]. 
2.2. PhtsmM ¢onstrurtion 
Construct SP6$/A4CT [1] was obtained by cloning the 961 bp Dell II 
ttindlll fra~nem of the APP595 eDNA clone [S] into pSP65, The 
resulting plasmid includes metllionine ¢odon 596 of AlaPfi95 as initia. 
tion codon, the anaylold ,BA4 Jequence (radons 597-6391640 of APP 
69S) and the entire COOH.tcrminal domain, 
For construction of SF651SPA4CT, plasmid SP6S/A4C'rl. which 
was obtained by cloninga NCOI oligolinker into SphllE¢oRl.diBested 
SPfS/A4CT, wa~ digested with NCOI, incubated with $1 to ereat, 
blunt ends and further digested with Hiudlll. The resulting eft0 bp
fragment carrying the A4CI" sequence was cloned into gPfSlfi95, di* 
gestcd with Asp 71tL incubated with $1 to cr~t¢ blunt endi and 
digested with//'iudIll. The resulting plasmid SP65/SPA4C~ ¢n~de'~ 
the APP ~ignal s~uence and two additional residues from APP695 in 
frame with the amyloid A4 ,sequence and the ntire COOH.terminal 
domain of the am),loid precursor. 
2,3, [n vitro trctnscription [[TJ 
DNA templates (100 ~g/ml) were transcril~d in 40 mM Trig, pH 
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?.5, 6 mM MIICI:, 2 mM Sl~rmidin=, 10 mM NaCI, 10 mM D'I-I', 
RNAsin (i Ul#l), 100 #Po/ntl BSA, S00 pM each of ATP. CTP and 
UTP. 50/tM GTP, and S00 pM m'G($')ppp(YlG, Typi~lly, I unit 
of SP6 RNA polymcra~ v~s added per/~g DNA template for u I h 
synthesis at 40"C, DTT and rNTPs stocks were prepared with dieth- 
ylpyrocarbonate-treuted water, The components of the tran~ription 
reaction were mixed at room tcmFrature to prevent DNA precipita- 
tion. 
Followinil RNA synthesis the DNA template ~,-as remm~l by the 
additic~n of RNA~-free DNA¢.  and after it 10 rain incubation at 
37"C. the reaction mixtures ~:re phenol:chloroform extracted after 
addition of NaOAe (pH S.S) to 0,3 M. The RNA was precipitated with 
ethanol and wu'=h=d with ?0,~= ethanol. 
2,4. t~ t'ilru trum'/ttlt.n 
Translation of mRNA in a ¢¢II.fr¢= rabbit rctieulocyt¢ ly~at¢ or a 
wheat prm expression system ~s  done followin= the pro~edur~ as 
described in the supplier',= manuals (Pro,nell, Germany). The reac. 
lions were c~rried out for 60 rain at 30°C " in the presence of SO.uCi 
of [~3]mcthionine and 0,$-I .0/,qt mRNA. 
Then the translation mixture was dilated with 2x La=mmli ~ample 
buffe='. After hcmtinll for l~l rain at 70°C, labeled proteins were anal- 
y~d by SDS-PAGE and fluoropaphy with EN~HANCE (Du l)ont), 
23. b...t.nprerlpitutio. I /XJ 
For immunoprecipitution, $0-100 pl of the ceil ly=ttc ~-4s diluted 
with 500 ml Sol buffer (SO mM Trls.HCl. pH 7,S, IS0 mM NuCI. I~  
NP.40, 2 mM PMSF) and incubated for 30 rain with Spl pre.immun. 
serum and 30 pl (3 mi}) protein A.$cphuros¢ (Pharma¢ia, Freiburg, 
Gcrntany), The ~n'~ples were brielly centrifutled and the sul'~raatu='~ts 
were incubated with S/JI of anti.runt for 60 mJn at room tempcrature, 
Followinl/, incubation, 30/tl (3 rag) protein A.Sepharos= was added 
for an additional 30 rain at room tcml'~r.tture, The insoluble =on~- 
plexes were washed once with wash A (10 taM Tris.HCl. pH 7.S. IS0 
mM NaCI. 0.2% NP-40. 2 mM EDTA): once with wash B (10 mM 
Tris.HCl, pH 7.5, :)00 mM NaCI. 01% N P,40, 2 mM EDTA) and once 
with v,-ash C (10 mM Tris.HCl. pH 7.5). TI~e r~llet was resusp;nded 
in 2x Luemmli sample buffer. After boilinl~ for 5 rain at 100°C. I;t. 
~iled proteins were ana l~d by SDS.PAGE and lluorogruphy with 
EN~HANCE (Du Pont), 
2,6, /ttmnhrntte s d/mentmi~, nnd c(trhumtt~ cxtractiun [19/ 
To sel~tivcly imlate inteBml men~bran¢ proteins, the translation 
products (20/Jl) obtained in the pr¢~ene= of microsomal membranes 
were diluted with 100/JI ice¢old 0.1 M Na_.CO~ pHI  1 ,nd incubated 
ut 0°C for 15 rain, Then the staples w=re layered over a sucrose 
cushion (50pl 0,25 NI sueroseJ0. I M Na_.CO~, pHI  I ) and ¢entrifutled 
for 10 rain at 30 psi in a Beckman airful~e usln~l the A.100130 rotor 
and cellulose propionate centrifuge tubes. Alter ccntrifugation the 
entire sup=rnatant includinl~ the sucres= cushion was removed :tad 
precipitated with an equal volume of 20% trichloro.tcetic acid. The 
pellet was resuspended in 10/tl 2% SDS. Samples used for protein 
S~lucnr.= analysis were dialysed aFtinst 0.01 M NH.=HCO) for ]6 h 
usinlt membranes with a cut-off value of 5,000, 
~-.7. Prutehl sequz.ce a.a/)'sis 
Amino-terminal sequelxe analysi~ was i'~rl'om~ed on :m Applied 
Biosystems model 470A tla~/liquid.phal¢ sequencer, For radiou:- 
quencinlt the PTH.umino acids wcr¢ collected, dried and dissolved in 
0,15 ml of methanol, After addition of 10 ml ofquickszint (Zi.ass=r), 
the radioactivity released at each cycle was detmnined in a Kontron 
liquid scintillation counter. 
2.8, Lipid extr.rtion: chh;rofon./.#¢thtmol cxtructh,. [201 
To 1 vol, of cell ly=ates or translation mixture were added 3.75 vols. 
of methanol-~hloroform (2:1, v/v), The mixture was shaken intermit- 
tently for 1-2 h, ~ntrifuged, and the SUl~=rnatant extract w.'n trans- 
l'erred to another tube, The remainder was then extracted ai]ain with 
4,75 vols, of m=thanol-chloroform-water (2:1;0.8, v/v). and the mix. 
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FiB, I, In vitro expmsion or A4CT and SPA4CT. rnRNA was tran. 
rcribrd from the correspondinll SPa vectonk translated in the RRL in 
the preener of [~S]mcthionine, immunoprecipitated an  unaly'~d by 
SDS.PAGE (12.S%). Lanes I and 9, in vitro trandution of A4CT in 
the RRL; lane 2. ~m¢ us lane I. bat translation in the pretence of 
naicrosomal membranes; lanes 3 and 8, ~In¢ us lane I, but post- 
tr.'tnslutionul incubation with 0.2~ Triton X. 100'. lane 4, in vitro trans. 
I,,ttion of SPA4CT in the RRL; lane $. same as lane 4. but translation 
in the presence of microsontal membranes; lane 6, ~me us lane 4° bat 
po~t.tr;tnsl;,tional i cubation with 0,2% Triton X.lq0: M. mole=ular 
muss marker; 
tur¢ w:t~ centrifullcd, The combined extracts were diluted with 23 
~,ols,. each of chloroform and water and than centrifulled, The lower 
ehloroforn~ pha~¢ was wi!hdrawn and the upper water pha~ was used 
I~r TCA precipitation. 
2.9. SDS.PAG[': 
Analysis of in vitro translation products by SDS-PAGE was per- 
formed accordinlt to Loan',nil 12ll , Prior to SDS-PAGE the samples 
were heated for S rain at 100'C in Laemmli sample baiter (0,0625 M 
Tris/HCI. pH 6,8, 2,5% SDS, 5% p.mercaptoathanol, 10% lllycerol, 
and 0.005% Bromophenol blueS. The lids were analyzed by flourosra. 
phy with EN~HANCE (Du Pont, Boston). 
3. RESULTS 
3. I. Espre~.~m, of a, ty/oid ~A4-co,ztai, hzfl seque, re; i, 
rabbit reticulocyte [ysctte:; 
Previously we reported the in vitro expression of the 
APP fragment termed A4CT in the rabbit rcticuloeyte 
lysate (RRL). A4CT has the methionin= residue preced- 
ing the anayloid ,6A4 sequence at the NH,.-terminus and 
includes the complete/~A4 sequence, the transmcm- 
brane domain and the cytoplasmic domain ot" APP. in 
Fig. 1. lanes 2 and 3 show that translation of A4CT, in 
the presence and absence of membranes, and subse- 
quent analysis by immunoprecipitation and SDS- 
PAGE did not result in a single band on SDS-PAGE 
but gave rise to a broad band at 17 kDa, and additional 
bands at approximately 20. 27, 40 kDa and hi~er mo- 
lecular weights. This is in agreeme,t with our previous 
finding that A4CT has a high tendency for asgre~tion 
[l]. 
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Fil~, 2. Analytis of membrane inrmrtion of A4CT and SPA4CT, Trans. 
In(ion as in Fill. l. The translation product,= were analy~d with the 
sedimentation =ts'~ay for inteilnt| membrane proteins. Lanes I and 2. 
~dimentation of $PA4CT mmslatcd in the absence (hm¢ l) or pres- 
ence (lane ..3) of tnembranes, Lanes 3 and 4, sediment;(finn of A4cr  
Iranslated in the ab~ncc tlan¢ 3) or presence O;m¢ 4) of membr,tnes. 
M, lallc with molecular mass tnarker proteit'~s. 
As shown recently, post-translational incubation of 
the A4CT translation products with 0.2~, Triton X-100 
prior to immunoprecipitation and aggregation analysis 
by gD$-PAGE influenced the aggregation pattern (Fig. 
1, lanes 4 and 8)[22]. The complex band pattern was 
reduced into one consisting of  only two prominctat 
bands at 17 and 26 kDa. Since A4CT carries the single 
transmembran, domain of APP, and since wc previ- 
ously demonstrated that APP is indeed a transmem- 
brahe protein, we analysed the properties of A4CT 
when inserted into membranes. For this we expressed 
plasmid SP65/SPA4CT, which encodes A4CT with the 
authentic signal sequence of APP. This protein is re- 
ferred to as SPA4CT. Expression of SPA4CT in the 
RRL should give rise to two different proteins depend- 
ing on the presence or absence of dog pancreas micro- 
somal membranes. In Fig. 1, lane $ shows that in the 
absence of membranes, SPA4CT-expression resulted in 
an aggregation pattern similar to that of A4CT.cxpres- 
sion. Only one additional band at 30 kDa was visible. 
In the presence of microsomal membranes, expression 
of the same construct SP65/SPA4CT resulted in one 
prominent broad band at 18 kDa on SDS-PAGE (Fig. 
I, lane 6). Unlike expression in the absence of mem- 
branes, no additional bands at higher molecular mass 
were de(co(able. This suggests that membrane insertion 
prevented aggregation of A4CT. 
Treatment of SPA4CT translated in the absence of
membranes with Triton X-100 reduced the complex ag- 
gregation pattern into only the monomeric band at 18 
kDa (Fig. 1, lane 7). Thus the aggrcgational behavior 
of" SPA4CT in the presence of Triton differs from that 
of A,~'I', which we propose to bc duc to the retained 
signal sequence in the absence of membranes. 
3.2. Analysis of membrane insertion 
Because SPA4CT translated in the presence of mem- 
branes did not aggregate, we analysed whether this mol- 
ecule ind~d becomes inserted into the membrane and 
thus protected from aggregation. Evidcn~ for a tight 
membrane association of SPA4CT was obtained with 
the sedimentation assay for integral membrane proteins 
[23]. SPA4CT translated in the presence of microsomes 
could be selectively sedimentatcd with the sodium car- 
bonate technique (Fig. 2, lanes 1 and 2), as expected for 
proteins inserted into he lipid bilayer. A4CT translated 
in the presence of membranes could also be sedimen- 
tated with the sodium carbonate technique (Fig. 2, lanes 
3 and 4). This shows that even in the absence of a signal 
sequence, A4CT strongly interacts with the microsomal 
vesicles. We attribute this effect to the presence of the 
APP transmembran, domain. 
To analyse whether the artificial signal sequence of 
gP65/SPA4CT was cleaved after membrane insertion. 
we sequenced [~S]Met-labeled SPA4CT protein synthe- 
sized in the cell.free system. For sequencing, membrane- 
inserted SPA4CT was enriched by the sodium carbon- 
ate technique. Radiosequence analysis revealed release 
of radioactivity at degradation step 37, which corre- 
sponds to methionine residue 54 of SPA4CT (Fig. 3). 
This result was compatible with the expected removal 
of the signal sequence of APP, which consists of 17 
residues [1]. This cleavage gen¢rated an A4CT variant 
with two additional residues at the NH.,-terminus. The 
two extra amino acids were introduced by the cloning 
procedure. The sequencing showed that if cloned in 
front of the flA4 sequence, th0 signal sequence of the 
anayloid flA4 precursor protein functioned as a mem- 
brane insertion signal. 
3.3. M'embra~te r mov.I 
To study the effects of membrane damage on the 
aggregationaI prop=rtics of SPA4CT, we removed the 
membranes prior to the addition of SD$ sample buffer, 
SPA4CT was sedimentated with the sodium carbonate 
technique, and the extraction of the membrane lipids 
was done with chloroform/methanol, The APP frag- 
ment was found in the initial methanol/chloroform 
phase. After further chloroform extractions, SPA4CT 
partitioned with the water phase. From there it was 
precipitated with trichlorcacetic acid. This treatment 
resulted in SPA4CT aggregates (Fig. 4, lane 2). Furtller- 
more, heating of this extracted APP fragment enhanced 
the aggregation process (Fig. 4, lane 3). Heating for 10 
min at [00oC without prior membrane extraction also 
led to aggregation of SPA4CT (data not shown). 
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Fill, 3. Radiosequen¢¢ analysis ofSPA4CT tra,~slated in the presence 
o1" membranes. Translation was as d¢-,¢ril~d for Fii. I. The peak of 
radioactivity at degradation step 37 is compatible with the expected 
removal of the I'/residues of the fi~nal ,~eqaen~ of APP ¢l~¢oded by 
SPA4CT, The amino acid =quen¢¢ 13i~s:n isthat for mature SPA4CT. 
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FiB. 4. Chloroform/methanol extraction ol mcm=m,©.m~rte.~ 
SPA4CT. SPA4CT was trunslat~ and sedimentated ~ described in 
Fig. 2. Lane l, sedimentation i'SPA4CT translated in the presence 
of membranes. Lane 2, ehlorofom'dmethanol ex|r'aetion of the tame 
tranflation product, Lane 3. healing of the extracted SPA4CT for l0 
rain at t00'C. M. lane with molecular mass marker proteins. 
4. DISCUSSION 
Previously we showed that expression of the COOH- 
terminal 100 residues of APP, ~=rmed A4CT, in the 
RRL resulted in an aggregating protein [1]. In this re. 
port we provide xperimental evidence that membrane- 
in-,crtc, d A4CT does not aggregate. 
As shown recently, the addition of detergent resolved 
the complex aggregation pattern of A4CT into two 
prominent bands at 17 and 26 kDa. We proposed that 
without detergent, A4CT undergoes a hydrophobic n- 
teraction with components of the RRL. and that the two 
pcomineng bands in the presence of detergent represent 
A4CT monomers and -dim=rs [22]. 
To analyse the role of membrane damage, which we 
propose is the prerequisite for amyloid formation [1,8], 
in A4CT aggregation, w¢ expressed A4CT together with 
a signal sequence (SPA4CT), which allowed us to syn- 
thesi~ membrane-inserted A4CT proteins. 
Expre'~sion of" SPA4CT without membranes resulted 
in an aggregation pattern similar to the aggregation 
pattern of A4CT, The slightly higher molecular mass of 
the SPA4CT aggregates at approximately 30 kDa is 
proposed to be due to the retention of the signal se- 
quence, which was not cleawd in the absence of mem- 
branes and which accounts for the additional 2 kDa. In 
the presence of detergent only monomerics could be 
detected, which indicates that in the absence of mem- 
branes, all observed interactions of SPA4CT are 
through hydrophobic residues. Since A4CT forms 
dimers under the same conditions, the different behav- 
ior of SPA4CT may be due to the additional hydropho- 
bic signal sequence. 
By membrane sedimentation and subsequent radiose- 
quencing, we could show that the signal sequence, of 
APP, if cloned in front of the flA4 sequence, is recog- 
nized by the signal pcptidase and allows membrane in- 
sertion of SPA4CT. Also, A4CT expressed without a 
signal sequence did selectively ~diment with mem- 
branes. These data suggest hat both proteins, A4CT 
and SPA4CT, were tightly associated with e mem- 
brane: SPA4CT due to the signal sequence and co- 
translational membrane insertion, and A4CT probably 
due to post-translational hydrophobic interactions of 
the transmcmbran¢ sequence with the membrane [ipids. 
Although both SPA4CT and A4CT can a~ociam with 
membranes, their aggregational behavior is different. 
Expression of SPA4CT in the presence of membranes 
resulted in only the monomeric molecule. This is not the 
case for membrane associated A4CT, which is still capa- 
ble of aggregating. This showed that membrane-inser- 
tion driwn by the signal sequence of APP interfered 
with the process of aggregation. 
Post-translational removal of the membrane lipids or 
heating restored the aggregationai properti=s of mem- 
brane-inserted SPA4CT. Both pro~darcs, heating and 
lipid extraction, can lead to membrane disruption, Thus 
SPA4CT may come in direct contact with the content 
of the RRL. In the context of our novel findings that 
the metal-catalyzed oxidation systems contained in the 
RRL in the form of hemoglobin, heroin and iron trans- 
formed non.aggregated A4CT into aggregated A4CT 
by radical attack and protein crosslinking [22]. we 
would propose that membrane insertion protects the 
part of SPA4CT relevant for aggregation from direct 
contact with the radical generation system and thus 
prevents the aggregation. 
From our results we assume that two steps of the 
process leading to amyloid formation in Alzheimer's 
disease require membrane damage. First, the COOH- 
terminal part of the ,/~A4 sequence is contained within 
the transmembran= domain of APP and is therefore 
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protected by the lipid bilayer from aberrant proteolytic 
processing which generates the COOH-terminus of the 
amyloidogenic ~A4 sequence. Thus cleavage at the 
COOH.tenninus of,~A4 requires membrane damage. 
Second, membrane insertion protects th0 amy- 
loidogenic fragmcm A4CT from protein crosslinking 
through radical attack. As we have shown recently, rad- 
ical attack transformed non-aggregated .~A4-bearing 
APP fragments into stable aggregated and amy- 
loidogenic molecules [22]. Also membrane damage is 
required for this amyloidogenic transformation induced 
by metal-~talyzed oxidation systems. 
Bemuse iron is considered to be the most probable 
agent responsible for lipid peroxidativc damage in tl~¢ 
brain, radical attack may be involved in several steps in 
amyloidogencsis in Alzh¢imer's disease [23]. Radical at- 
tack may release ~A4-bearing APP-fi'--~gments from the 
lipid bilayer by means of peroxidative damage of the 
membrane lipids, and subsequent radicals may also 
transform the released non-aggrc~tcd ~A4 bearing 
APP fragments into stable aggregated, nd thus amy- 
Ioidogenic. molecules. 
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